Literature DB >> 2985642

Rescue of IgM, IgG, and IgA production in common varied immunodeficiency by T cell-independent stimulation with Epstein-Barr virus.

G Jeong, P Ralph, I Nakoinz, O Saiki, C Cunningham-Rundles.   

Abstract

We previously defined three categories of B-cell defects in common varied immunodeficiency (CVI): failure to produce IgG and IgA in response to T cell-dependent (TD) stimulation by Staphylococcus bacteria (Sac) plus pokeweed mitogen or B-cell inducing factor (BIF), failure to produce any immunoglobulin, and failure of Sac-induced proliferation and differentiation. The present study includes the responses of 22 CVI patients to T cell-independent (TI) stimulation by Epstein-Barr virus (EBV). In the majority of patients, EBV-stimulated B cells showed normal proliferation and IgM production. In addition, IgG and IgA production was in the range of that for EBV-stimulated normal cells in many patients. Among 11 patients with no TD production of immunoglobulin of any isotype, two showed normal IgM secretion in response to EBV and five others had significant but subnormal responses. Four patients never had humoral responses despite repeated testing and removal of potentially suppressing T cells and monocytes. Concanavalin A stimulation of the T cells from all the patients tested resulted in the production of B-cell inducing factor at higher levels than for normal donor T cells, as assayed on normal Sac-stimulated B cells. These results show that many cases of B-cell defects in CVI patients involving TD production of IgM, switching to TD production of IgG and IgA, and mitogen responses to Sac are not absolute defects. The B cells will respond normally to some stimuli.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2985642     DOI: 10.1007/bf00915010

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  26 in total

Review 1.  A new approach to the study of human B lymphocyte function using an indirect plaque assay and a direct B cell activator.

Authors:  A G Bird; S Britton
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

2.  Immunoglobulins on the surface of lymphocytes in fifty patients with primary immunodeficiency diseases.

Authors:  J L Preud'Homme; C Griscelli; M Seligmann
Journal:  Clin Immunol Immunopathol       Date:  1973-01

3.  Induction of human immunoglobulin secretion. II. T lymphocyte dependency and radiosensitivity of T-cell help for induction of B-cell differentiation by Staphylococcus aureus strain Cowan I.

Authors:  O Saiki; P Ralph
Journal:  Cell Immunol       Date:  1982-07-01       Impact factor: 4.868

4.  Pathophysiologic analysis of peripheral blood lymphocytes from patients with primary immunodeficiency. I. Ig synthesis by peripheral blood lymphocytes stimulated with either pokeweed mitogen or Epstein-Barr virus in vitro.

Authors:  H Mitsuya; K Osaki; S Tomino; T Katsuki; S Kishimoto
Journal:  J Immunol       Date:  1981-07       Impact factor: 5.422

5.  Epstein-Barr virus-induced immunoglobulin synthesis by B cells from individuals with late-onset panhypogammaglobulinemia.

Authors:  P L Haber; H Kubagawa; M D Cooper
Journal:  J Clin Immunol       Date:  1983-07       Impact factor: 8.317

6.  Human B cell-inducing factor(s) for production of IgM, IgG and IgA: independence from IL 2.

Authors:  P Ralph; K Welte; E Levi; I Nakoinz; P B Litcofsky; R H Mertelsmann; M A Moore
Journal:  J Immunol       Date:  1984-04       Impact factor: 5.422

7.  The cellular basis for viral-induced immunodeficiency: analysis by monoclonal antibodies.

Authors:  E L Reinherz; C O'Brien; P Rosenthal; S F Schlossman
Journal:  J Immunol       Date:  1980-09       Impact factor: 5.422

8.  Purification of human interleukin 2 to apparent homogeneity and its molecular heterogeneity.

Authors:  K Welte; C Y Wang; R Mertelsmann; S Venuta; S P Feldman; M A Moore
Journal:  J Exp Med       Date:  1982-08-01       Impact factor: 14.307

9.  The suppression of Epstein-Barr virus infection in vitro occurs after infection but before transformation of the cell.

Authors:  D A Thorley-Lawson
Journal:  J Immunol       Date:  1980-02       Impact factor: 5.422

10.  Characteristics of Epstein-Barr virus activation of human B lymphocytes.

Authors:  A G Bird; S Britton; I Ernberg; K Nilsson
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

View more
  3 in total

1.  Clinical and immunologic analyses of 103 patients with common variable immunodeficiency.

Authors:  C Cunningham-Rundles
Journal:  J Clin Immunol       Date:  1989-01       Impact factor: 8.317

2.  Measurement of peripheral B cell subpopulations in common variable immunodeficiency (CVID) using a whole blood method.

Authors:  B L Ferry; J Jones; E A Bateman; N Woodham; K Warnatz; M Schlesier; S A Misbah; H H Peter; H M Chapel
Journal:  Clin Exp Immunol       Date:  2005-06       Impact factor: 4.330

Review 3.  Common variable immunodeficiency.

Authors:  C Cunningham-Rundles
Journal:  Curr Allergy Asthma Rep       Date:  2001-09       Impact factor: 4.806

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.